Source: Artsenkrant – “Nachtmodus: dialyse aan” (September 4, 2025)
Artsenkrant is a Belgian medical news platform that provides healthcare professionals with in-depth reporting on clinical practice, policy developments, and technological innovation. In one of their recent features, they explore the future of dialysis and the cutting-edge technologies that could reshape kidney replacement therapy.
Every day, our kidneys silently filter 30 to 50 times the body’s entire blood volume with extraordinary precision. But when kidney failure occurs, millions worldwide rely on dialysis or hope for a transplant—a treatment option that remains limited by donor shortages and long waiting times.
For most patients, dialysis is the only lifeline. Standard hemodialysis requires patients to spend around 12 hours per week in hospital settings, attached to large machines that consume vast amounts of water and energy. While life-saving, this treatment often leaves patients fatigued, dizzy, or nauseous, and restricts their mobility and independence.
Despite being in use since Willem Kolff’s pioneering machine of the 1940s, dialysis technology has changed little in principle. But innovations are now emerging that could transform the field. Portable dialysis devices are already in clinical testing. These machines regenerate and reuse dialysate, cutting fluid consumption from 120 liters down to just 5, and fitting into a suitcase-sized unit—offering patients greater freedom.
Even more promising are chip-based nanofilters, currently under development at imec and other research centers. These ultrathin membranes, with highly uniform nanopores, filter waste molecules like urea and creatinine while retaining essential proteins such as albumin. Their high porosity allows blood filtration under natural blood pressure, eliminating the need for external pumps and reducing strain on the body.
Such nanofilters could enable the creation of compact, energy-efficient, and patient-friendly dialysis systems that better mimic natural kidney function. Future systems may even integrate sensors and microelectronics to continuously monitor patient health and transmit real-time data to caregivers.
The ultimate vision is an implantable artificial kidney: a fully autonomous device combining nanofiltration, biocompatibility, and rechargeable power systems. While challenges remain -especially in durability and integration- progress in microfluidics, bioelectronics, and materials science suggests this leap is no longer a question of if, but when.
As Artsenkrant emphasizes, achieving this vision will require close collaboration between engineers, clinicians, and policymakers to ensure that smarter, more humane dialysis technologies can reach patients sooner.